| Trial ID: | L6433 |
| Source ID: | NCT00124397
|
| Associated Drug: |
Atorvastatin
|
| Title: |
Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Atorvastatin
|
| Outcome Measures: |
Primary: Flow mediated vasodilatation (FMD) on atorvastatin | Secondary: FMD on combined treatment|FMD in relation to lipid levels|FMD in relation to BP lowering|CV events
|
| Sponsor/Collaborators: |
Sponsor: University of Southern Denmark | Collaborators: Pfizer
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
186
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: PREVENTION
|
| Start Date: |
2001-07
|
| Completion Date: |
2004-12
|
| Results First Posted: |
|
| Last Update Posted: |
2005-08-05
|
| Locations: |
Department of Medical Research, SHF Svendborg, Svendborg, 5700, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00124397
|
